Encyclopedia of Public Health

2008 Edition
| Editors: Wilhelm Kirch

Rubella Vaccination

Reference work entry
DOI: https://doi.org/10.1007/978-1-4020-5614-7_3074


Rubella immunization; German measles immunization; German measles vaccination; Three-days measles vaccination; Three-days measles immunization


The course of rubella is harmless for the patient, both in childhood and in adulthood. However, if the first infection occurs during pregnancy, it represents a great threat to the embryo. For this reason, the number of rubella antibodies (antibody titer) in women in the early stage of pregnancy is checked in order to determine their immunity to rubella. The rubella vaccination was introduced in 1969/1970. Nowadays, it is generally applied in combination with the vaccination against measles and mumps (MMR). The patient receives the first inoculation at a minimum of 11 months of age and a second vaccination at an interval of at least 4 weeks later. The protection rate is 95%. Contraindications for rubella or MMR vaccination are immunodeficiency, acute illness with fever, pregnancy and a known severe allergic...

This is a preview of subscription content, log in to check access.

Copyright information

© Springer-Verlag 2008